PMID- 34170412 OWN - NLM STAT- MEDLINE DCOM- 20220329 LR - 20220701 IS - 1432-198X (Electronic) IS - 0931-041X (Linking) VI - 37 IP - 1 DP - 2022 Jan TI - Maternal antibiotic exposure during pregnancy is a risk factor for community-acquired urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in infants. PG - 163-170 LID - 10.1007/s00467-021-05163-z [doi] AB - BACKGROUND: This study aimed to investigate the risk factors for community-acquired urinary tract infection (UTI) caused by extended-spectrum beta-lactamase (ESBL)-positive bacteria in infants. METHODS: We retrospectively reviewed the medical records of infants aged < 1 year with first UTI from 2018 to 2019 at two tertiary centers in Korea. Data analyzed included clinical findings, birth history, delivery mode, milk type, use of postpartum care center, and previous use of antibiotics both in the patient and mother. RESULTS: Of 265 patients, 62 (23.4%) were diagnosed with first UTI caused by ESBL-positive bacteria at the median age of 3.6 (interquartile range (IQR) 2.3-5.4) months. Maternal use of antibiotics during pregnancy (29.0 vs. 10.3%, p < 0.001) and Klebsiella species (19.4% vs. 4.9%, p < 0.001) were significantly associated with ESBL-positive UTIs and remained valid in the multivariate analysis (odds ratio [OR], 3.40; 95% confidence interval [CI] 1.61-7.19, p = 0.001, and OR 5.26; 95% CI 2.03-13.13, p = 0.001, respectively). Previous antibiotic exposure of patients, previous hospitalization, prematurity, delivery mode, milk type, and use of postpartum care center were not significantly different between ESBL-positive and ESBL-negative groups. With respect to the clinical course of UTI, the ESBL-positive group presented a higher number of blood leukocytes (p = 0.041) and longer hospital stay (p < 0.001) than the ESBL-negative group. CONCLUSIONS: About one-fourth of infantile UTI cases were ESBL-positive. Prenatal antibiotic exposure of mothers and Klebsiella species were associated with community-acquired UTI caused by ESBL-positive bacteria. CI - (c) 2021. IPNA. FAU - Kim, Ji Hyun AU - Kim JH AD - Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. AD - Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea. FAU - Lee, Juyoung AU - Lee J AUID- ORCID: 0000-0001-7548-2284 AD - Department of Pediatrics, Inha University Hospital, Incheon, Republic of Korea. FAU - Kim, Dong Hyun AU - Kim DH AUID- ORCID: 0000-0001-9883-0229 AD - Department of Pediatrics, Inha University Hospital, Incheon, Republic of Korea. FAU - Park, Ji Young AU - Park JY AUID- ORCID: 0000-0002-6777-0494 AD - Department of Pediatrics, Chung-Ang University Hospital, Seoul, Republic of Korea. FAU - Lee, Hyunju AU - Lee H AUID- ORCID: 0000-0003-0107-0724 AD - Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. AD - Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea. FAU - Kang, Hee Gyung AU - Kang HG AUID- ORCID: 0000-0001-8323-5320 AD - Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea. AD - Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea. AD - Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea. AD - Wide River Institute of Immunology, Seoul National University, Hongcheon, Republic of Korea. FAU - Ahn, Yo Han AU - Ahn YH AUID- ORCID: 0000-0002-8185-4408 AD - Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea. yhahn@snu.ac.kr. AD - Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea. yhahn@snu.ac.kr. AD - Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea. yhahn@snu.ac.kr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210625 PL - Germany TA - Pediatr Nephrol JT - Pediatric nephrology (Berlin, Germany) JID - 8708728 RN - 0 (Anti-Bacterial Agents) RN - EC 3.5.2.6 (beta-Lactamases) SB - IM CIN - Pediatr Nephrol. 2022 May;37(5):1167-1168. PMID: 35118537 MH - *Anti-Bacterial Agents/adverse effects MH - Bacteria/enzymology MH - *Community-Acquired Infections/epidemiology/microbiology MH - Female MH - Humans MH - Infant MH - Pregnancy MH - *Prenatal Exposure Delayed Effects/epidemiology MH - Retrospective Studies MH - Risk Factors MH - *Urinary Tract Infections/epidemiology/microbiology MH - beta-Lactamases/metabolism OTO - NOTNLM OT - Infants OT - Klebsiella OT - Multiple antibacterial drug resistance OT - Prenatal care OT - Risk factors OT - Urinary tract infection EDAT- 2021/06/26 06:00 MHDA- 2022/03/30 06:00 CRDT- 2021/06/25 12:21 PHST- 2021/01/29 00:00 [received] PHST- 2021/05/28 00:00 [accepted] PHST- 2021/05/23 00:00 [revised] PHST- 2021/06/26 06:00 [pubmed] PHST- 2022/03/30 06:00 [medline] PHST- 2021/06/25 12:21 [entrez] AID - 10.1007/s00467-021-05163-z [pii] AID - 10.1007/s00467-021-05163-z [doi] PST - ppublish SO - Pediatr Nephrol. 2022 Jan;37(1):163-170. doi: 10.1007/s00467-021-05163-z. Epub 2021 Jun 25.